ESMO Symposium on Metastases
Invited speakers will provide an international expertise on the basic science and its clinical translation to practice for lymph node, hematopoietic, brain, lung, liver and bone metastases. Lectures will cover traditional and new concepts in research of metastases, including ectopic homing, dormancy, early colonization and migration. The program will also cover the biological rationale for new therapeutic strategies, drugs in development, the use of biomarkers and therapy resistance. A special part of the Symposium will be dedicated to the pathophysiology of bone metastases, their prevention, functional imaging, multidisciplinary management and clinical application and integration of bone-targeted treatments.
The program is designed for basic scientists, experts in clinical translation of basic science findings to practice,
medical oncologists, surgeons, radiotherapists, and organ-based specialists. In addition, interventional radiologists, imaging specialists, pathologists, those involved in the clinical trials for anti-metastatic agents, supportive care specialists and research nurses can benefit from attending.
Learning objectives
* Learn about the developmental processes involved in metastases
* Recognize biomarkers in determining potential for distant metastases
* Understand the basis of emerging treatment targets and novel strategies in the management of cancer
* metastases
* Grasp the multidisciplinary aspects in the research, prevention, diagnosis, treatment and palliation of cancer
* Metastases
Benefits in attending
* To receive a high scientific level overview in the field of cancer metastases with concurrent coverage of clinical aspects and practice applicability
* An ideal place for scientists and clinicians to disseminate information
* Provides excellent possibility to exchange opinions within interactive environment
* Excellent exposure to info not diluted at general oncology conferences
* Focus on hot topics in cancer metastases research of interest to multiple disciplines
* Encourages research team on cancer metastases integration and enhances discussion among specialists
* Provides excellent networking opportunities